Jonathan Phillips

About Jonathan Phillips

At Intellia Therapeutics, I\'m leading nonclinical strategy as Vice President of Pharmacology & Toxicology. My experience developing gene editing therapies began at Vertex where I co-authored first-in-human applications for CTX001 (CASGEVY), in partnership with CRISPR Therapeutics. I\'ve also built and led several translational and investigative safety teams during my time with Boehringer Ingelheim. Prior to industry, I was a Bioastronautics Fellow at NASA Ames Research Center in Mountain View, CA where we investigated basic principles of mechanobiology in space travel environments. I hold a PhD in cell biology from UMass-Worcester, where I was a NASA funded candidate. My 20+ year scientific record includes dozens of peer reviewed publications, book chapters, and invited presentations.

Experience

1. Managing Editor

   Eclipse Scientific Editing

   May 2005 — Present

   Editing firm specializing in polished biomedical communication. Long track record of repeat Japanese and European clients. Services include reviewing and revising peer reviewed manuscripts, grants, posters and slides.

Education

• University of Massachusetts Graduate School of Biomedical Sciences

  Doctor of Philosophy - PhD, Cell Biology, Tissue Engineering, Mechanobiology

• Florida Institute of Technology

  Bachelor of Science - BS, Pre-Medicine/Pre-Medical Studies

• Florida Institute of Technology

  Bachelor of Science - BS, Molecular Biology

Skills

• Biochemistry
• Drug Discovery
• Translational Medicine
• Clinical Development
• Fantasy Baseball
• Biotechnology
• Oncology
• Drug Development
• Emotional Intelligence
• Pharmaceutical Industry
• Toxicology
• Tissue Engineering
• Biomarkers
• Sandwiches
• Molecular Biology
• Cell
• Biomarker Discovery
• Science Journalism
• Tissue Culture
• In Vitro
• Biomarker Development
• Life Sciences
• Assay Development
• Cell Biology